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ABSTRACT
Since the development of gene therapy, a variety of non-viral nucleic acid delivery vehicles
have been prepared and studied for their transfection efficiencies. Recently, polymeric gene
delivery vehicles have gained popularity for their low immunogenicity and high transfection
efficiency. With the advent of controlled radical polymerization (CRP) and more specifically
reversible addition-fragmentation chain transfer (RAFT) polymerization, it is now possible to
develop well-defined polymers with predicted molecular weights and architectures. The work
presented here focuses on the RAFT polymerization of a family of amphiphilic, cationic
copolymers to be utilized for nucleic acid delivery. These copolymers are composed of a
stabilizing hydrophilic block of oligo(ethylene glycol) methyl ether methacrylate (OEMGA) and
a cationic, endosomolytic block of 2-(dimethylamino) ethyl methacrylate (DMAEMA), 2(diethylamino) ethyl methacrylate (DEAEMA), or 2-(diisopropylamino) ethyl methacrylate
(DPAEMA). The hydrophilic content of this copolymer series was kept constant while the degrees
of polymerization of the cationic block of 25, 50, and 75 were targeted to elucidate the effects of
tertiary amine functionalization on gene delivery efficacy. Means of characterization included gel
permeation chromatography (GPC), dynamic light scattering (DLS), electrophoresis, and in vitro
gene expression and toxicity studies. As a result from this study, our findings indicate the
significance of cationic group functionalization on siRNA delivery, and the pH-responsive nucleic
acid delivery vehicles synthesized show promise for future studies of nucleic acid delivery.
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̅n
𝑀

Number-average molecular weight

̅w
𝑀

Weight-average molecular weight

PDI

Polydispersity index

CRP

Controlled radical polymerization

NMP

Nitroxide mediated radical polymerization

ATRP

Atom-transfer radical polymerization

RAFT

Reversible addition-fragmentation chain transfer polymerization

CTA

Chain transfer agent

CSIRO

Commonwealth Scientific and Industrial Research Organization

MADIX

Macromolecular design via the interchange of xanthates
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Theoretical number-average molecular weight

macroCTA

Macro chain transfer agent

PEI

Poly(ethyleneimine)

PEG

Poly(ethylene glycol)

DMAEMA

2-(dimethylamino) ethyl methacrylate

OEGMA

Poly(oligo(ethylene glycol) methyl ether methacrylate)

PEGMA

Poly(ethylene glycol) methyl ether methacrylate

DEAEMA

2-(diethylamino) ethyl methacrylate

BMA

Butyl methacrylate

PAA

Propylacrylic acid
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DPAEMA

2-(diisopropylamino) ethyl methacrylate

GPC

Gel permeation chromatography

TAE

Tris-Acetate EDTA

DLS

Dynamic light scattering

CDP

4-cyano-4-[(dodecylsulfanylthiocarbonyl)sulfanyl] pentanoic acid

V-501

4,4’-azobis(4-cyanovaleric acid)

DMSO

Dimethyl sulfoxide

DMEM

Dulbecco’s minimal essential medium

qPCR

Quantitative polymerase chain reaction
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CHAPTER 1
POLYMERIZATION METHODS
By definition, a polymer is type of macromolecule containing a long sequence of repeating
subunits; to create such molecules, a chemical synthesis or polymerization must be performed.
Polymers, as a general term, can be subdivided into two broad categories, namely, naturally
existing polymers such as DNA and proteins as well as synthetic polymers such as plastics,
rubbers, and some pharmaceuticals.1 Since polymers have such a wide range of uses in various
industries, it is important to gain a deeper understanding of the potential characteristics and
properties made possible by the numerous polymerization techniques.

1.1

Introduction to Polymers
Much like the characterization of small molecules, polymers can be categorized by their

chemical composition as well as their structural arrangement. Polymers are classified as either a
homopolymer or a copolymer. A homopolymer contains only a single type of repeat unit or
monomer molecule. Plastics such as polyethylene and polypropylene are examples of such
homopolymers. Copolymers on the other hand are made up of two or more different species or
types of repeat units. Our DNA is an example of a naturally occurring copolymer while butyl
rubber, as found in the inner lining of tires, is a synthetic copolymer. Copolymers can then be
further subdivided by the arrangement of the different monomer species within the polymer.1
Examples of homopolymer and copolymer arrangements can be found in Figure 1.1.
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Figure 1.1 Homopolymer and copolymer architectures. Illustrated copolymer structures are AB
statistical, AB alternating, AB diblock, AB graft, ABA triblock, and ABC triblock.

It is important to note that these different copolymer architectures can be used for a
multitude of purposes in a variety of industries depending on the properties desired for the polymer
and the application. Statistical and alternating copolymers exhibit properties that are intermediate
of the corresponding homopolymers while block and graft copolymers generally exhibit full
characteristics of each of the homopolymer blocks.1 Polymers, therefore, can be synthesized with
essentially any collection of physical properties depending on the monomer units and copolymer
structure.
The properties of a polymer can also be affected by the size or length of the polymer chain;
therefore, it is imperative to characterize the polymer dimensions by the molecular weight or the
related degree of polymerization. Polymers, unlike small molecules, have a distribution of
molecular weights. This distribution can be defined by either the number-average molecular
̅ n) or the weight-average molecular weight (𝑀
̅ w) as shown in Equations 1.1 and 1.2
weight (𝑀
respectively.
2

̅ n = Σ XiMi =
𝑀

̅ w = Σ wiMi =
𝑀

Σ Ni M i
Σ Ni
Σ Ni M2i
Σ Ni M i

(Eq. 1.1)

(Eq. 1.2)

As defined in Equation 1.1, the number-average molar mass is the sum of the products of
a molecule’s molar mass (Mi), and the mole fraction (Xi) of that particular molar mass in the
polymer sample. Similarly as defined in Equation 1.2, the weight-average molecular weight is the
sum of the molecules with weight fraction (wi) in the polymer multiplied by the molar mass of the
̅ w/𝑀
̅ n, is known as the
molecules in this weight fraction. The ratio of these two values, 𝑀
polydispersity index (PDI) which indicates the width of the molar mass distribution and gives
insight into the range of molecular weights of a given polymer. Should the PDI near unity, the
polymer would be considered monodisperse meaning that all of the polymers are of roughly the
same length and molecular weight.1 To quantify the number of repeat units of a given species with
the polymer structure, the degree of polymerization is calculated by dividing the molecular weight
of the polymer by the repeat unit molecular weight as shown in Equation 1.3.
𝑥̅ n =

1.2

̅𝑛
𝑀
𝑀0

(Eq. 1.3)

Polymerization Principles
To create a polymer, as briefly mentioned, a series of reactions must occur to chemically

link a number of monomer units together. For this process to be possible, the monomer molecules
must have a functionality of two or more. In other words, the monomer must be capable of reacting
with at least two other monomers so to form a link of monomer units which ultimately leads to the
formation of a polymer. Considering that there are many varieties of chemical reactions and
3

polymerization methods with even more monomer molecules available, it is best to categorize
polymerization reactions into two categories: step-growth polymerization and chain-growth
polymerization.1 A generalized schematic for both of these polymerization methods is illustrated
in Table 1.1.

Table 1.1 Schematic for step-growth and chain-growth polymerizations (o: monomer repeat unit,
I: initiator species).
Step-Growth
Dimer

o + o → o-o

Trimer

o-o + o → o-o-o

Tetramer
Pentamer

Chain-Growth
I + o → I-o
I-o + o → I-o-o
I-o-o + o → I-o-o-o

o-o-o + o → o-o-o-o
o-o + o-o → o-o-o-o
o-o-o-o + o → o-o-o-o-o
o-o-o + o-o → o-o-o-o-o

I-o-o-o + o → I-o-o-o-o
I-o-o-o-o + o → I-o-o-o-o-o

For step growth polymerizations, reactions can occur between any two molecular species
in the polymerization solution in order to grow the polymer chains. Though monomer molecules
are consumed quickly during the early phases of the polymerization, the degree of polymerization
increases throughout the reaction since two polymer chains can join to form one much larger
polymer chain. One negative aspect of this polymerization method though is that it is not ideal for
synthesizing large molecular weight polymers. Since the monomers are consumed early in the
reaction, only polymer chains are available to move around in solution and react with each other
to form the larger polymer chains. Even moderately long polymer chains do not move well in
solution since steric hindrance affects the range of motion and molecular diffusion. This loss of
mobility means large molecular weight polymers are more difficult to synthesize by step growth
polymerization.1

4

On the other hand in chain-growth polymerizations, monomer molecules are consumed
throughout the entire polymerization reaction, and larger molecular weight polymers with high
degrees of polymerization are possible. Once polymerization has been initiated, the chain growth
occurs very rapidly with successive additions of monomer molecules to the growing polymer
chain. When the polymer chain becomes terminated, it is no longer able to propagate, and the
overall degree of polymerization does not change; however, the number of polymer chains formed
increases.1

1.3

Radical Polymerization
Radical polymerizations, one type of chain grown polymerization, are the most widely used

polymerization method to date and are known for their versatility to utilize a wide range of
unsaturated monomers. The polymer grows by the reaction between an unsaturated molecule and
a molecule containing a free radical as shown in Scheme 1.1. Being a type of chain growth
polymerization, propagation during a radical polymerization occurs by the sequential additions of
monomer units to the radical reactive site otherwise known as the active center. For all radical
polymerizations, the free radical on the end of the chain attacks a monomer causing homolytic
cleavage of the π-bond. One electron from this broken π-bond forms a new covalent bond between
the two molecules, and the lone, free electron then moves to the terminal carbon atom creating a
new active center.1

Scheme 1.1 Radical polymerization mechanism. The polymer growth is indicated by sequential
addition of an unsaturated molecule to the active center to create a new active center.
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Radical polymerizations can be further divided into two main categories: conventional free
radical polymerization and controlled radical polymerization (CRP). These two categories mainly
differ by the amount of time that the free, active radicals are present during the polymerization
process. For free radical polymerizations, the radical sites are active for most of the time during
the polymerization; however, for CRP, the radical sites are only active for short bursts of time. The
CRP techniques afford better control over the resulting polymers as much research has been
completed in this area since their development in the 1990s.1

1.4

Controlled Radical Polymerization
For reversible-deactivation polymerizations the radical sites are only active for a short

amount of time since they are temporarily deactivated throughout the polymerization by being
reversibly trapped by another molecular species. The CRP techniques, utilizing the reversibledeactivation strategy, work to limit termination events resulting in the polymerization techniques
maintaining most of the active sites throughout the polymerization. If all of the polymer chains
can be initiated at the same time, the end result yields a polymer with a PDI close to one.1 This
living quality of the CRP methods makes them very valuable in a number of industries such as
pharmaceutics.2-4
There are two documented mechanisms to gain the pseudo-living quality of the CRP
methods. The first strategy involves a reversible end-capping process as shown in Figure 1.2a.
Here, a chain-capping species (denoted R) reversible reacts with a propagating radical chain. The
polymer can only grow when species R is not bound to the radical chain, and it ceases propagation
when the chain-capping species is bound. The second CRP strategy utilizes a degenerative chain
transfer mechanism as illustrated in Figure 1.2b. This strategy relies on a chain transfer reaction in

6

which a free radical chain displaces the non-radical chain causing a transfer of the active species
from one chain to another. Both the reversible end-capping and degenerative chain transfer
strategies must include a rapid, reversible exchange of the active species to ensure that each
polymer chain grows with the same probability. Also, due to the temporary deactivation of radical
species throughout the polymerization that results in low radical concentrations, termination events
for both strategies are almost completely suppressed1.

(a) Reversible end-capping

(b) Degenerative chain transfer

Figure 1.2 Controlled radical polymerization strategies: (a) reversible end-capping method and
(b) the degenerative chain-transfer strategy.

There are three main types of CRP methods: nitroxide mediated radical polymerization
(NMP), atom transfer radical polymerization (ATRP), and reversible addition-fragmentation chain
transfer (RAFT) radical polymerization. Both NMP and ATRP utilize the reversible end-capping
strategy while RAFT utilizes the degenerative chain-transfer mechanism. Briefly, NMP employs
nitroxide radicals as the end-capping group while ATRP utilizes a transition metal-halide
7

complex.1 RAFT, on the other hand, utilizes a chain transfer agent (CTA) to mediate the
degenerative chain transfer process.1-2, 5-6

1.5

RAFT Polymerization
Reversible addition-fragmentation chain transfer (RAFT) polymerization was first reported

in 1998 by the Commonwealth Scientific and Industrial Research Organization (CSIRO) in
Australia.5-6 Independently, a French research group led by Bouhadir patented the same process
under the name Macromolecular Design via the Interchange of Xanthates (MADIX).8-9 Though
the names differ, both polymerization methods are dependent on a degenerative chain transfer
process utilizing a controlling agent for polymer synthesis. Since its invention, RAFT has become
one of the most widely used polymerization methods because of the variety of tolerable functional
monomers available and because it creates near monodisperse polymers of well-defined molecular
weight and architecture.2

1.5.1

RAFT Mechanism
The RAFT polymerization mechanism, as illustrated in Scheme 1.2, utilizes a

thiocarbonylthio CTA to support the living polymerization characteristics associated with the
controlled radical polymerization methods. The main stages of RAFT polymerization are the
initiation or generation of radicals, activation of the CTA, propagation of polymers, and
termination of the polymer chains.1-2, 10
To initiate RAFT polymerizations, primary radicals must be generated as with any
traditional radical polymerization method (Scheme 1.2; Reaction 1); therefore, initiation processes
utilizing energy sources such as heat, UV radiation, or gamma radiation may be employed.
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Contrary to conventional radical polymerization methods, the primary radical species react with
and activate the RAFT chain transfer agent.1-2, 10 Some common thermal initiators are shown in
Figure 1.3. 4, 10

Scheme 1.2 RAFT polymerization mechanism. Reaction steps include (1) radical initiation of the
initiator species utilizing heat or radiation, (2, 3) CTA activation by a radical species and preequilibrium with formation of oligomers, (4) main equilibrium of the RAFT polymerization with
propagating polymer chains, and (5) termination of polymer chains.

9

Figure 1.3 Common thermal initiators.

Once there are radical species in solution, the activation of the RAFT agent can occur by
one of two different mechanisms (Scheme 1.2, Reactions 2 and 3). Since the monomer
concentration is much larger than the CTA concentration, the primary radical has a higher
probability of activating a monomer molecule over a RAFT agent (Scheme 1.2, Reaction 2). The
activated monomer species can then react with either other monomer units or the RAFT agent.
Considering the high chain transfer constant of the CTA, it is unlikely that many monomers will
react with the activated monomer before reacting with a CTA. Once the CTA has been activated
forming the intermediate species, the fragmentation process occurs when the leaving group
homolytically cleaves and is now able to react with monomers in solution. In order to ensure this
R group fragmentation, it is advantageous to choose a CTA in which the R group is a better free
radical leaving group than the activated monomer. Alternatively, the primary radical may directly
react with the CTA forming the intermediate radical (Scheme 1.2, Reaction 3). Again, the
fragmentation process occurs, and the leaving R group can now propagate in solution by reacting
with monomer molecules.1-2, 10
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It is important at this time to note the ratios of the polymerization mixture in order to make
the kinetics of this pre-equilibrium step, as well as the overall RAFT mechanism, more apparent.
Ideally, there will be a CTA to initiator ratio ranging from 2:1 to 10:1. The CTA controls the
number of polymer chains while the initiator dictates the number of free radicals in the system.
Since the initial initiator concentration is much less than the initial CTA concentration, there will
be more dormant polymers in the system than activated polymer chains. The pre-equilibrium stage
encompasses the activation of the RAFT agents and the beginning of polymer formation in which
only oligomers are formed.2, 10 After all of the CTAs have been activated, the polymerization
moves into the main equilibrium stage in which the bulk of the monomer molecules are consumed.
It is this point in the polymerization that the living characteristics become apparent (Scheme 1.2,
Reaction 4). Here, the CTAs undergo the degenerative chain transfer process between polymer
chains with only the radical species propagating in solution while the thiocarbonylthio species
remains dormant.1-2
For termination of the polymerization to occur, a few situations are possible. The reaction
can go to completion to the point where there are no more monomer molecules in solution able to
react with propagating polymer chains. The reaction mixture can also be introduced to an
atmosphere containing a high concentration of radical species such as oxygen. Bimolecular
reactions in which two radical chains undergo a combination or disproportionation termination
process ultimately leading to a dead polymer are also possible. Once the polymer chains are
inactive from a termination process, they can no longer propagate and the polymerization is
complete.10
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1.5.2

RAFT Chain Transfer Agent (CTA)
The chain transfer agent is imperative to the RAFT polymerization process in order to

successfully achieve the desired living conditions; therefore, the CTA must be carefully chosen
for each RAFT polymerization. A wide variety of thiocarbonylthio RAFT agents with the general
structure RSC(=S)Z have been identified and reported in the literature. Figure 1.4 illustrates the
four subcategories of the thiocarbonylthio structural family including dithioesters, xanthates,
dithiocarbamates, and trithiocarbonates. An effective RAFT agent must have a reactive carbonsulfur double bond (C=S) and result in a radical that can reinitiate the polymerization process. The
CTA must also give an intermediate radical that favors the elimination of the free radical leaving
group. Some commonly used RAFT agents are illustrated in Figure 1.5. 2, 4, 10

Dithioester

Xanthate

Dithiocarbamate

Trithiocarbonate

Figure 1.4 General structure of the RAFT chain transfer agents.

When choosing a CTA for the desired polymerization, it is imperative to recognize how
the CTA will interact with the monomer and resulting polymer chains. These interactions are what
ultimately affecting the RAFT polymerization kinetics.4, 10 Figure 1.6 illustrates the structures of
a dithioester RAFT agent throughout the polymerization process.2 Compound (1) includes the
reactive C=S double bond as well as a Z group capable of activating this double bond.10-11 The
intermediate radical illustrated by compound (2) includes two free radical leaving groups, R and
R’. For this CTA to be effective, the R group must contain a weaker single bond capable of
fragmenting from the CTA intermediate. Also, the Z group ensures stabilization for the duration
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of the equilibrium. Finally, once the R group has fragmented and is a free radical in solution, it
must be capable of reinitiating polymerization. Then the addition-fragmentation chain transfer
mechanism occurs in the opposite direction to develop a new propagating radical thus moving the
polymerization process into the main equilibrium.2, 10

CTP

CMP

CDP

DMP

BDB

CDB

Figure 1.5 Commonly used chain transfer agents in RAFT polymerization.

Figure 1.6 CTA structures during RAFT polymerization

1.5.3

Molecular Weight Control
RAFT polymerization is well known for its control over the polymer molecular weight.

The innate living conditions provided by the RAFT agent in part allows for this regulation over
13

the molecular weight; however, there are other conditions that must be met to afford the desired
control. The two main sources of polymer chains during the RAFT polymerization process are the
radical initiator fragments formed from homolytic cleavage of the initiator as well as the radical
CTA leaving groups formed from the CTA fragmentation step. Taking these radical sources into
consideration, the equation for the theoretical number-average molecular weight (𝑀𝑛,𝑡ℎ ) from a
RAFT polymerization is given in Equation 1.4.

Mn,th =

[M]0
MMW
ρ
[CTA]0
f
[I]0
kd
CTAMW

[𝑀]0 𝑀𝑀𝑊 𝜌

[𝐶𝑇𝐴]0 +2𝑓[𝐼]0 (1−𝑒 𝑘𝑑 𝑡 )

+ CTAMW

Eq. 1.4

initial monomer concentration
monomer molecular weight
monomer conversion
initial CTA concentration
initiator efficiency
initial initiator concentration
initiator decomposition rate constant
CTA molecular weight

From the denominator of Equation 1.4, it can be determined that the CTA to initiator
concentration plays a role in the control of the polymer molecular weight. Should the ratio of
[CTA]0:[I]0 be sufficiently high, the fraction of polymer chains initiated from radical initiator
fragments will be less than 5% of the overall polymer chain sources7; therefore, the initiator term
in the denominator can typically be ignored, and Equation 1.4 can be simplified to Equation 1.5.

Mn,th =

[𝑀]0 𝑀𝑀𝑊 𝜌
[𝐶𝑇𝐴]0

+ CTAMW

Eq. 1.5

This equation now clearly indicates a linear relationship between polymer number-average
molecular weight and monomer conversion (ρ); therefore, after analysis of experimental kinetic
14

data of the desired RAFT polymerization, polymers of a predetermined molecular weights and
narrow polydispersity can be produced.10

1.5.4

Block Copolymer Synthesis
Block copolymers have a wide range of applications since they express characteristics of

the homopolymer components as well as properties resulting from homopolymer linking. RAFT
polymerization is a powerful method for the development of complex polymer architectures, and
it is commonly employed for the synthesis of block copolymers.1-2 Polymers synthesized via
RAFT polymerization contain a thiocarbonylthio end group in the polymer structure. This
polymer, now termed the macro chain transfer agent (macroCTA), reacts similarly to the low
molecular weight CTA utilized for developing homopolymers, and it can be chain extended with
another monomer species to form the desired AB diblock copolymer.2 The generalized RAFT
synthesis of diblock copolymers is illustrated in Figure 1.7.

Figure 1.7 General mechanism for the RAFT synthesis of diblock copolymers
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Much like homopolymer synthesis, after initiation the propagating polymer chain will
undergo addition to the macroCTA by attacking the π-bond of the thiocarbonylthio end group. The
originally dormant polymer will then preferentially fragment from the intermediate species
resulting in a new active polymer capable of chain extending with the second monomer species.
The originally active polymer is now dormant with the thiocarbonylthio end group.1-2
Polymer sources during diblock copolymer synthesis originate from the radical initiator
fragments from the original initiation step and the polymer radicals that have fragmented from the
macroCTA intermediate compound. Knowing these polymer chain sources, the block copolymer
molecular weight can be calculated similarly to that of a homopolymer as denoted in Equation 1.6
with the percentage of dead polymer chains defined in Equation 1.7.2

Mblock copolymer =

[𝑀]0 𝑀𝑀𝑊 𝜌

[macroCTA]0 +2𝑓[𝐼]0 (1−𝑒 𝑘𝑑 𝑡 )

[M]0
MMW
ρ
[macroCTA]0
f
[I]0
kd
MmacroCTA

% dead chains =

+ MmacroCTA

(Eq. 1.6)

initial monomer concentration
monomer molecular weight
monomer conversion
initial macroCTA concentration
initiator efficiency
initial initiator concentration
initiator decomposition rate constant
macroCTA molecular weight
2𝑓[𝐼]0 (1−𝑒 𝑘𝑑 𝑡 )

[macroCTA]0 +2𝑓[𝐼]0 (1−𝑒 𝑘𝑑 𝑡 )

(Eq. 1.7)

It can be inferred that a high [macroCTA]0:[I]0 ratio indicates that the majority of the
polymer chains are generated from the macroCTA; therefore, the molecular weight calculation for
a block copolymer can be simplified to Equation 1.8 by neglecting the initiator terms. A linear
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relationship between block copolymer molecular weight and monomer conversion can now be
observed, and the polymerization kinetics can be somewhat predicted to produce polymers of welldefined molecular weight and architecture. The high [macroCTA]0:[I]0 ratio also indicates an
inverse relationship between dead polymer chains and initial macroCTA concentration; therefore,
having a higher concentration of macroCTA in the polymerization solution would cause most of
the polymer chains to remain in the main equilibrium stage of RAFT polymerization resulting in
a polymer of low molecular weight dispersity.

Mblock copolymer =

[𝑀]0 𝑀𝑀𝑊 𝜌
[macroCTA]0
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+ MmacroCTA

(Eq. 1.8)

CHAPTER 2
GENE DELIVERY
Gene therapy is a novel approach to replacing or modifying the use of drugs or other
therapies that treat symptoms in patients.12 This therapeutic method utilizes a gene delivery vehicle
to transport genetic material into affected cells in order to alter expression of existing genes,
supplement existing proteins, or induce cytotoxic activity. Though the first gene therapy trials
began in 1990, it wasn’t until the year 2000 that the first successful gene therapy treatment was
reported. With this success came an increased interest in the development of gene therapies,
lending to the pursuit of a safe and effective gene delivery vehicle for clinical use.13
Both viral and non-viral gene delivery vehicles have been studied and characterized for
their gene delivery efficiencies. The production of non-viral vehicles has gained much more
attention, however, since viral vectors tend to induce an immunogenic response and are considered
toxic to cells.14-15 The two categories of non-viral vehicles studied are natural polymers such as
chains of amino acids and synthetic polymers (usually cationic) with the majority of the research
focused on developing new synthetic polymers. One major limitation with these gene delivery
vehicles though is that their molecular interactions with cells are poorly understood adding a layer
of complexity to the development of efficient delivery vehicles.3 Some barriers to successful
nucleic acid delivery include cellular uptake, endosomal escape, and delivery efficiency of genetic
material to the nucleus; therefore, polymers must be produced to overcome these known barriers
so gene therapies can move forward in development.3, 14-15
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2.1

Gene Delivery Mechanism
Though the full delivery mechanism and corresponding cellular interactions are not

completely understood, the known barriers can be applied to the accepted gene delivery
mechanism as illustrated in Figure 2.1. In order to produce efficient polymeric gene delivery
vehicles, it is imperative to develop an understanding of this delivery mechanism.

Cationic
Polymer

Genetic
Material

Polyplex
Formation

Endocytosis

Release

Nucleus
Entry

Figure 2.1 Mechanism for the delivery of genetic material by means of cationic polymer.
Polymer and genetic material combine by electrostatic interactions, enter the cell by
endocytosis, release into the cytoplasm, and the genetic material enters the nucleus.

The first step to gene delivery is the complexation of the delivery vehicle with the genetic
material. Synthetic, cationic polymers are attracted to the negatively charged phosphate backbone
of the genetic material by electrostatic interactions. The polymer and genetic material, once
complexed, are termed a polyplex.16 This polyplex, having an overall positive charge, is attracted
to the negatively charged phospholipid bilayer of the cell exterior, again by electrostatic
interactions. The polyplex then enters the cells by means of endocytosis. Once inside the cell, the
genetic material and polymer are released into the cytoplasm leaving the genetic material to enter
the nucleus and affect the cell17; the means of intracellular release, however, is under debate.
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2.1.1

Proton Sponge Effect
There are multiple theories used to explain the endosomal escape pathway once the

polyplex is taken up by the cell. One theory, termed the proton sponge effect, is illustrated in Figure
2.2. After endocytosis, the polyplex resides in an endosome which is known to facilitate
degradation of foreign material; therefore, in order for the gene delivery vehicle to transport the
genetic material to the nucleus, it must induce an endosomal escape mechanism.17 To degrade
foreign material, the endosome utilizes an ATPase proton pump enzyme to decrease the internal
pH to acidic values of pH 5-6 moving it into the late endosomal stage. It then further traffics the
material to a lysosome which has an even lower pH value of approximately 4.5.17 Once the
trafficking mechanism reaches this point, the polymer and genetic material cannot escape to the
cytoplasm and are degraded. To overcome this endosomal trafficking and degradation, the gene
delivery vehicle can be designed with cationic polymers of a desired pKa value. Should the cationic
polymer have a large number of titratable side chains, namely in the form of secondary or tertiary
amines, the pKa value can be tapered between the physiological pH and the pH of a lysosome.
Once this cationic polymer enters the endosome, it will induce a larger influx of protons in order
to protonate the amine groups. With this larger proton influx, comes a larger counter ion influx of
chloride ions which then induces a larger intake of water molecules to compensate for the increased
ion concentrations. It is this increase in water concentration that increases the osmotic pressure of
the endosome eventually reaching a maximum point causing the endosome to burst. Once the
endosome bursts, the genetic material is free in the cytoplasm to travel to the nucleus and obtain
the desired biological activity.17-19
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Figure 2.2 Mechanism for endosomal release as described by the proton sponge hypothesis.

2.2

Previous Studies
In order to take advantage of the endosomal escape mechanism by means of the proton

sponge effect, certain cationic polymers have been extensively studied. Poly(ethyleneimine) (PEI),
in particular, is known as the gold standard of cationic gene delivery vehicles since it has been
reported to have high efficiency of polyplex formation as well as high gene expression15, 20;
however, this purely cationic polymer induces immunogenic responses both in vitro and in vivo
because of it nonspecific interactions with proteins and cells.14-15,

21

Another limitation with

utilizing cationic polymers such as PEI includes the lack of control over the molecular weight and
architecture of the resulting polymers. Knowing these limitations, there is an inherent need to
develop polymers with a hydrophilic section to impart polyplex stability and decrease cell toxicity
as well as a need to develop or utilize a polymerization method that would afford control over the
polymer synthesis in order to create polymers of well-defined molecular weights and architectures.
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2.2.1

RAFT and Gene Delivery
With the advent of controlled radical polymerization (CRP), and more specifically RAFT

polymerization, control over the synthesis of well-defined molecular weight polymers is now
possible. Since the initial report on RAFT polymerization in 1998, many advances in the
development of gene therapies have occurred. One significant adaptation of RAFT polymerization
allowing for these advances is the ability to produce water-soluble, functional polymers, allowing
not only the molecular weights and architectures of the polymers to be controlled, but
biocompatibility of the polymer can also be afforded making RAFT polymerization ideal for
developing gene delivery vehicles.3-4, 10 A brief summary of the more common hydrophilic and
pH-responsive monomers polymerized by RAFT and used for gene delivery purposes is shown in
Figure 2.3 and Figure 2.4 respectively.3, 10
In the sections to follow, a number of previous works will be discussed. These publications
report their findings on the RAFT synthesis of “smart” gene delivery vehicles. These copolymers
are considered smart in that they contain a cationic moiety with a pKa range around that of
physiological conditions; therefore, they will respond to the pH gradient present in the endosomal
pathway and induce the proton sponge effect. The first studies to be discussed will elucidate the
effects of the addition and structural manipulation of the hydrophilic content to the gene delivery
vehicle22-24 while the remainder of this chapter will focus on varying the endosomolytic block to
deduce their effects on the nucleic acid delivery efficiency.28-31
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Figure 2.3 Hydrophilic monomers polymerized by RAFT for use in gene delivery vehicles.
Oligo(ethylene glycol) methyl ether methacrylate (OEMGA), N-Isopropylacrylamide (NIPAM),
Butyl methacrylate (BMA), 2-Hydroxyethyl methacrylate (HEMA), and 3-Hydroxypropyl
methacrylamide (HPMA)

Figure 2.4 pH-responsive monomers polymerized by RAFT for use in gene delivery vehicles. 2Dimethylaminoethyl methacrylate (DMAEMA), 2-Diethylaminoethyl methacrylate (DEAEMA),
2-Diisopropylaminoethyl methacrylate (DPAEMA), 4-Vinyl pyridine (4VP), and Acrylic acid
(AA)
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2.2.2

Hydrophilic Architecture
PEI, though the gold standard for gene delivery, is known to induce an immunogenic

response as a result of its nonspecific interactions with cells and proteins. In order to overcome
this toxicity, it has been proposed to conjugate the cationic polymer with a hydrophilic,
biocompatible polymer.3, 14-15, 22-24 This hydrophilic segment then increases polyplex stability in
physiological conditions as well as decreases cell toxicity making cationic polymers a more tenable
for gene therapy use. One common way of improving the biocompatibility of the polymer is to
incorporate poly(ethylene glycol) (PEG) into the copolymer design, eventually coining the term
PEGylated copolymer.22-24
In 2002 and 2004, Deshpande et al. reported findings on PEGylated cationic copolymers
containing the tertiary amine functionalized monomer 2-(dimethylamino) ethyl methacrylate
(DMAEMA).22-23 For this study the topology of the hydrophilic block was modified to elucidate
its effect on gene delivery. Three different hydrophilic architectures were developed for this study
by chain extending DMAEMA with different PEG-containing molecules as outlined in Table 2.1.
Being linear in its natural state, PEG was utilized to develop a linear diblock copolymer as
illustrated in Figure 2.5a. Two different PEG-functionalized polymers were then used to produce
brush and comb-type copolymer structures. Poly(oligo(ethylene glycol) methyl ether
methacrylate) (OEGMA) containing 7-8 PEG repeat units as side chains composed the hydrophilic
content of the brush diblock copolymer (Figure 2.5b) while poly(ethylene glycol) methyl ether
methacrylate (PEGMA) having 45 ethylene glycol repeat units as side chains was employed for
the comb-type statistical copolymer (Figure 2.5c). Though PEG is present for all copolymers in
this study, the percentage of this hydrophilic polymer differs among the different architectures.
Since PEGMA contain PEG side chains 45 ethylene glycol units long, the degree of polymerization
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of PEGMA as reported gives the statistical copolymer a higher overall PEG content as compared
to the two diblock copolymers which contain similar hydrophilic content. Interestingly, the
statistical copolymer also contains a larger number of DMAEMA repeat units giving the
copolymer more protonatable side chains as compared to the diblock copolymers. Once
synthesized, the copolymers were then studied in vitro in order to characterize and determine their
gene delivery efficiency and cell toxicity. Three different cell lines, namely COS-7, human A549,
and HepG2 cells, were used for the in vitro studies. From these characterization experiments, it
was revealed that modification of the PEG architecture does have an effect on the gene delivery
efficacy. Deshpande et al. reported similar transfection efficiencies for both the brush and linear
diblock copolymers across all cell lines with the exception of the brush copolymer in the A549
cell line in which low gene expression was observed. The comb-type statistical copolymer,
however, indicated low transfection efficiencies for all three cell lines. From a cytotoxic
standpoint, the linear copolymer induced the most toxic effects resulting in the lowest cell viability
of the copolymers studied; this polymer was also reported to have a concentration dependent
toxicity with higher polymer concentration indicating lower cell viability. In contrast, both the
block and statistical copolymers indicated similar high cell viability despite the polymer
concentrations.22-23
Table 2.1 Properties of tertiary amine methacrylate polymers by Deshpande et al.22-23; m denotes
the cationic degree of polymerization and n denotes the PEG-containing moiety degree of
polymerization
Polymer
DMAEMA
DMAEMA-OEGMA
DMAEMA-PEG
DMAEMA-stat-PEGMA

Mn
5130
8600
7800
21000

25

m
32
37
37
66

n
6-7
45
5

Mw/Mn
1.18
1.12
1.25
1.11

(a)

(b)

(c)

Figure 2.5 Structures of tertiary amine methacrylate polymers by Deshpande et al.22-23

In 2011, a similar study by Venkataraman et al. was published and reported findings on
DMAEMA PEGylated copolymers.24 For this study, the architecture of the hydrophilic block was
again modified; however, the PEG weight fractions were similar among all polymers produced.
The degree of polymerization of DMAEMA was also maintained to ensure the amount of cationic
charge did not vary within the copolymer series. Like Deshpande, Venkataraman et al. aimed to
define gene delivery efficiencies based solely on the topology of the PEG units. Here, PEG and
OEGMA were again utilized for the linear diblock and brush diblock configurations respectively;
however, unlike Deshpande, OEGMA was also utilized for the statistical copolymer. These
hydrophilic polymers were then chain extended with DMAEMA to develop a series of PEGylated,
cationic copolymers. In all, three copolymer structures were synthesized (Table 2.2). The
generalized structure of these three polymers is outlined in Figure 2.6 while the synthesis
illustrated in Scheme 2.1. After synthesis, the copolymers were then characterized in vitro to better
understand their gene delivery efficiency and cell toxicity. Transfection experiments were carried
out in both HEK293 and HepG2 cell lines to determine if the copolymer mediated transfection is
cell type dependent. From these experiments, Venkataraman et al. also concluded that the PEG
architecture has an effect on the gene delivery efficacy. Here, however, the reported trend indicated
that the linear diblock copolymer induced higher gene expression as compared to the statistical
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and brush block copolymers in both cell lines utilized. Interestingly, a cell dependent transfection
efficiency was observed for all polymers with lower expression levels in the HepG2 cells. Cell
toxicity was also studied utilizing the same two cell lines as in the transfection experiments, and
cell dependent toxicity levels were reported. HEK293 cells were noted to have higher cell viability
as compared to the HepG2 cells. Similar viabilities were observed for all copolymer architectures
in the HEK293 cells; however, the polymers except the statistical comb-type copolymer induced
a toxic effect in the HepG2 cells.24

Table 2.2 Characterization of compositionally equivalent and topologically different PEGylated
cationic polymers by Venkataraman et al.24
Copolymer

̅ n (Da)
𝑀

mPEG-b-p(DMAEMA)
p(DMAEMA-co-OEGMA)
(a)
(b)
(c)
p(OEGMA)-b-p(DMAEMA)

+ +
+

No. nitrogen
atoms
49

10700
15000
196000
11800

0.24
0.22
0.23
0.22

46
67
90
53

+

+

+
+

10100

PEG weight
fraction
0.20

+

+

+

+ + +
+ + + +

Figure 2.6 Schematic representation of model PEGylated cationic polymers containing
different architectures of equivalent PEG components (represented by blue line) and
comparable cationic components (represented by gray lines with positive charges) by
Venkataraman et al.24
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Scheme 2.1 RAFT polymerization-based synthetic route for the compositionally equivalent and
topologically different PEGylated poly(dimethylaminoethyl methacrylate) based macromolecules,
where the architecture of PEG chains was systematically varied to result in diblock copolymer (2),
statistical copolymer (3a-c) and brush-block copolymer (5) by Venkataraman et al.24

As a result of these studies, it was proposed that the architecture of the hydrophilic
PEGylated content does have a significant effect on the transfection efficiencies of gene delivery
vehicles. Though these works do disagree on overall trends indicated from transfection
experiments, both authors conclude that the block topology, whether linear or brush-type, indicates
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better nucleic acid delivery and gene expression than that of the statistical copolymer. As for cell
viability, it was concluded that the copolymers have cell dependent toxic effects with the statistical
copolymer inducing less of an immunogenic response as compared to the block topologies.22-24
Additionally, it is worth noting that of the PEGylated molecules studied, only OEGMA and
PEGMA can be synthesized with the polymerization control afforded by RAFT since they contain
the needed reactive double bond. Therefore, moving forward, it would be advantageous to focus
on utilizing OEGMA block copolymers for gene delivery purposes since these copolymers indicate
low toxicity and high gene expression levels, and RAFT can be employed for synthesis purposes.

2.3.3

pH-Responsive, Cationic Polymers
Since it has been determined that PEGylation of cationic polymers increases the

biocompatibility of the gene delivery vehicle, it now becomes imperative to develop polymers
capable of successfully escaping the endosome before degradation. To produce such polymers, it
is advantageous to utilize pH-responsive monomers capable of capitalizing on the proton sponge
effect. Monomers that are considered pH-responsive are those that take advantage of a changing
pH environment by altering their degree of ionization depending on the pH of the surrounding
solution. For example, weak polyacids become more protonated by accepting protons at higher
pH values while weak polybases become protonated at lower pH values. The actual ionic charge
of the polyacids is negative at higher pH values while the opposite holds true for polybases in that
they are positive at lower pH values.10 Since the genetic material has a negative charge, it would
be advantageous to further develop gene delivery vehicles utilizing polybases as they hold a
positive charge in the lower pH values present in endosomes.
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One type of pH-responsive monomer includes polybases containing a tertiary amine group.
Of these tertiary amine containing monomers, DMAEMA has been the most extensively studied
since the first reports of CRP and RAFT polymerization mainly due to its high transfection
efficiencies and endosomal destabilizing properties.25-27 The following studies to be discussed will
focus on the RAFT polymerizations utilizing tertiary amine-containing monomers such as
DMAEMA to synthesize gene delivery vehicles. The overall goal of this section is to deduce
effects on how changing components of the endosomolytic block influences transfection
efficiencies and cell toxicity.
In 2012, Hinton et al. published their work on the RAFT polymerization of ABA triblock
copolymers designed for gene delivery. The copolymers were composed of the hydrophilic, PEGfunctionalized monomer OEGMA (A-block) and the cationic DMAEMA monomer (B-block).
Briefly, the DMAEMA macro chain transfer agent (macroCTA) was synthesized utilizing a bisRAFT agent capable of producing the triblock copolymer functionality. The DMAEMA
macroCTA was then chain extended with OEGMA in one of two different methods. The first of
which utilized the raw product of macroCTA synthesis; therefore, DMAEMA monomers were still
in solution and capable of copolymerizing with the OEGMA producing statistical A-blocks. For
the second method the macroCTA was purified before chain extension with OEGMA; therefore,
the resulting A-blocks consisted of pure hydrophilic content. Once synthesized, the copolymers
then were subject to a quarternization reaction so that the DMAEMA repeat units would carry a
permanent positive charge despite changing pH. Table 2.3 outlines a summary of the polymers
synthesized for this study while Scheme 2.2 illustrates the polymerization schematic. The naming
scheme found in Table 2.3 indicates the triblock architecture ABA followed by the number of PEG
monomers/number of DMAEMA repeat units; Q indicates a quasi tri-block as synthesized from
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polymerization method 1 while P indicates a pure tri-block synthesized from polymerization
method 2. The triblock copolymers were synthesized with various A and B block lengths with the
ultimate goal to determine the most efficient and least toxic copolymer structure. To characterize
the ABA triblock copolymers, Hinton et al. utilized CHO-GFP and HEK293 cells to elucidate the
copolymer effect on cell toxicity while only CHO-GFP cells were employed for cellular uptake
and gene silencing assays. Hinton et al. reported that of the cationic B-block lengths studied, the
range of DMAEMA repeat units between 110 and 120 was ideal for cellular uptake across the
range of cells studied. Additionally, it was noted that decreasing the cationic block length caused
a decrease in cellular uptake while increasing it caused an increase in cytotoxicity.

Table 2.3 The number average molecular weight, dispersity, and composition of the block
copolymers prepared from DMAEMA and OEGMA475 using RAFT polymerization from Hinton
et al.28
ID*

Polymerization
Block B
Tri-block
Number of
% of
Method
(PDMAEMA):
ABA:
repeat units
DMAEMA
molar mass
molar mass
in each
in A blocks
(Mn in kDa)/
(Mn in kDa)/
block:
dispersitya
dispersitya
A-B-Ab
ABA-7/38Q
1
6.8/1.12
13.8/1.13
7-38-7
2.7
ABA-15/82Q
1
13.7/1.09
28.3/1.22
15-82-15
6.0
ABA-58/108P
2
17.9/1.15
73.1/1.72
58-108-58
0.0
ABA1
18.6/1.17
84.6/1.75
69-113-69
5.5
69/113Q
ABA-33/110P
2
15.1/1.25
47.9/1.33
33-110-33
0.0
ABA1
19.2/1.11
39.5/1.44
21-117-21
5.0
21/117Q
ABA1
23.6/1.15
40.5/1.26
18-145-18
5.0
18/145Q
ABA1
31.0/1.22
66.6/1.85
37-192-37
5.2
37/192Q
a
As determined by gel permeation chromatography (GPC) against polystyrene standards.
b
Calculated from GPC data before quarternization of the polymers.
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Scheme 2.2 Reaction scheme representing the synthesis of RAFT-derived ABA tri-block
copolymers by Hinton et al.28

As for the varying OEGMA block lengths, it was concluded that all of the A-blocks with
at least 15 OEGMA repeat units and some DMAEMA composition were efficient at delivering the
genetic material. The authors postulate that this increased positive charge from incorporating
DMAEMA into the hydrophilic blocks aids in the condensing of the genetic material. The
positively charged DMAEMA units of the A-block are attracted to the negatively charged nucleic
acids in the core of the polyplex making the entire complex aggregate more than if there were no
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DMAEMA repeat units in the A-block; this attraction ultimately leads to better protection of the
genetic material. In addition, the statistical copolymer being produced by the one pot method
affords simplicity for the tri-block polymerization process since the intermediate purification step
is not performed. Therefore, overall it was determined that an ABA triblock copolymer containing
statistical A-blocks of hydrophilic and cationic content and a B-block of permanent positive charge
yields the most efficient gene delivery vehicle.28
A study completed in a 2012 by Manganiello et al. analyzed the gene delivery efficiency
of diblock copolymers composed of DMAEMA, 2-(diethylamino)ethyl methacrylate (DEAEMA),
and butyl methacrylate (BMA). The DMAEMA macroCTA was synthesized and subsequently
chain extended with various ratios of DEAEMA and BMA as shown in the reaction schematic in
Scheme 2.3.
Scheme 2.3 RAFT-mediated synthesis of a diblock copolymer consisting of a cationic
poly(DMAEMA) block and an endosomolytic hydrophobic block incorporating DEAEMA and
BMA at varying molar feed ratios from Manganiello et al.29
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Unlike the previous studies utilizing DMAEMA for nucleic acid complexation,
Manganiello utilized the DMAEMA block for polyplex formation as well as for hydrophilic
stabilization as opposed to using a PEGylated monomer. The pH-responsive DEAEMA/BMA
block was included for its endosomolytic activity. Like DMAMEA, DEAEMA also contains
tertiary amine side chains capable of protonation in low pH environments; therefore, it can escape
the endosomal pathway by the same mechanism. To deduce effects of added hydrophobic content
to the endosomolytic block, the BMA percentages ranged from 20-70% in the B-block. These
polymers having both cationic and hydrophobic content has a proposed endosomal escape
mechanism in which the tertiary amine groups of DMAEMA and DEAEMA become protonated
under decreasing pH conditions causing an increase in the positive charges of the polyplex core
and corona. With DMAEMA being cationic as well, electrostatic repulsion will cause the polyplex
to destabilize, therefore, releasing the genetic material. Additionally, increasing the hydrophobic
content of the B-block causes the polyplex to be more stable since the hydrophobic moieties stay
aggregated under aqueous conditions; therefore, by changing the DEAEMA to BMA ratio, the
release mechanism could be optimized. After characterization experiments in vitro utilizing
RAW264.7 and JAWSII cell lines, increasing transfection efficiency with decreasing BMA
content was reported; however, this trend also holds true for cell toxicity with increasing toxicity
for decreasing BMA content. Manganiello reported that copolymers containing 30-40% BMA
content (60-70% DEAEMA) in the B-block exhibited the transition from inert to endosomolytic
at those pH values expected in the endosome, providing the most promising gene delivery platform
of the study.29
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Scheme 2.4 RAFT-mediated synthesis of diblock copolymers consisting of a cationic
poly(dimethylaminoethyl methacrylate) (DMAEMA, x=58) block and an endosomolytic
polyampholyte block incorporating DMAEMA and propylacrylic acid (PAA) in equimolar ratios,
and butyl methacrylate (BMA) (y~70) from Convertine et al.30

Similarly, in 2009 Convertine et al. reported on a copolymer family based on a comparable
endosomal escape pathway to that of Manganiello.30 In this study, a DMAEMA macroCTA was
chain extended with varying ratios of DMAEMA, BMA, and propylacrylic acid (PAA) (Scheme
2.4). For the B-block, the feed ratios of DMAEMA and PAA were kept the same while the BMA
content was varied. Again, DMAEMA is positively charged while BMA is hydrophobic. PAA,
however, is negatively charged becoming protonated (less negatively charged) upon decreasing
pH. Therefore, in the lower pH environments of the endosome, the PAA loses negative charge
while the DMAEMA increases in positive charge, and by electrostatic repulsion among
DMAEMA molecules, the polyplex is destabilized. The results of in vitro studies utilizing HeLa
cells indicated that the polymer with the highest BMA content (50%) showed the highest level of
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siRNA uptake. The cytotoxicity study indicated similar cell viability for all polymers analyzed in
this study. As with Manganiello, Convertine et al. suspect a relationship between then BMA
content of the endosomolytic block and the transfection efficiency of the copolymer.30 Here, 50%
BMA content was concluded as most the efficient polymeric gene delivery vehicle while
Manganiello reported 30-40%.29-30 The difference, however, can be explained by the different Bblock content and endosomal escape mechanism of the these two studies.
In 2013 Nelson et al. reported on the PEGylated copolymers of DMAEMA copolymerized
with BMA.31 A linear PEG macroCTA was chain extended with various ratios of DMAEMA and
BMA as illustrated in Scheme 2.5. The goal of this study was to identify a PEGylated gene delivery
vehicle with an optimized B-block ratio of cationic and hydrophobic content. The previous studies,
though analyzing the cation and hydrophobic ratios as well, did not include a PEGylated moiety
for steric stability. From the studies in LR-3T3 and MDA-MB-231 cells, they noticed an inverse
relationship between the BMA content in the polymer and the transitional pH of the micelles. The
greater the BMA content, the lower the pH of the surrounding environment needed to be in order
to induce the endosomolytic activity. This same trend was recognized and reported in both reports
by Manganiello et al. and Convertine et al.29-30 The conclusion of the study by Nelson et al. was
the copolymer containing 50% BMA has the optimum ratio of positive charge to hydrophobicity
and efficiently delivers the genetic material to induce a biological response.31
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Scheme 2.5 Polymer synthesis scheme for PEG-(DMAEMA-co-BMA) from Nelson et al.31

Much research has been reported on the gene delivery efficacies of polymeric gene delivery
vehicles. With the advent of CRP methods and RAFT polymerization in particular, it is now
possible to synthesize polymers of well-defined molecular weights and architectures as well as
biocompatible polymers containing hydrophilic segments for polyplex stability and toxicity
control. Upon analysis of the previous works presented in this chapter, it is apparent that
PEGylation of cationic polymers affords a biologically compatible copolymer ideal for gene
delivery purposes. The addition of hydrophobic content in the cationic block of a copolymer has
also been reported to increase the gene delivery efficacy. Interestingly, the variance of the cationic
block without hydrophobic content is yet to be extensively studied or reported; therefore, it would
be a worthwhile study to deduce the effects of cationic content and functionality on the gene
delivery efficiency and cell toxicity.
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CHAPTER 3
RAFT POLYMERIZATION FOR THE SYNTHESIS OF TERTIARY AMINE-BASED
DIBLOCK COPOLYMER NUCLEIC ACID DELIVERY VEHICLES

3.1

Abstract
A wide range of nucleic acid delivery vehicles have been studied for their efficacy in gene

therapy, and with advances in controlled radical polymerization (CRP) techniques, the synthesis
of precise polymeric architectures needed for these delivery vehicles is now possible. The
development of a family of pH-responsive, diblock copolymers designed to effectively delivery
genetic material is reported. The polymers were prepared by RAFT polymerization utilizing an
oligo(ethylene glycol) methyl ether methacrylate (OEGMA) stabilizing block and a cationic block
derived from a family of pH-responsive, tertiary amine-containing methacrylates, namely 2(dimethylamino) ethyl methacrylate (DMAEMA), 2-(diethylamino) ethyl methacrylate
(DEAEMA), 2-(diisopropylamino) ethyl methacrylate (DPAEMA), capable of complexing with
negatively charged nucleic acids. Nine copolymers were synthesized utilizing the same
hydrophilic block length while varying the degree of polymerization of the cationic block to
lengths of 25, 50, and 75 monomer units. The polymers were characterized by gel permeation
chromatography (GPC) to determine their molecular weight and polydispersity. To characterize
the binding affinity of the siRNA/polymer complexes, electrophoresis and dynamic light scattering
(DLS) experiments were carried out in various pH environments to mimic the pH values present
in the early and late endosome. The diblock copolymers condensed siRNA at all N/P ratios at pH
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5, while less binding affinity was observed with increasing pH. At all pH values, the polyplexes
indicated particle sizes less than 25 nm in diameter, ideal for cell entry. In vitro studies utilizing
HEK293 and MCF-7 cells were employed to evaluate cell toxicity and determine polymeric gene
delivery efficiency. The cytotoxicity study indicates high cell viability with the diblock
copolymers with the exception of E50 and E75 while the gene knockdown experiments indicated
high siRNA delivery efficiency for all nine copolymers. As a result, this copolymer family will
enable further studies and development for promising gene delivery vehicles capable for clinical
use.

3.2

Introduction
Since the emergence of gene therapy, a number of gene delivery vehicles have been

characterized for their gene delivery efficacies.3, 10, 32-33 It has been reported from various studies
that viral vectors indicate high toxicity and immunogenicity; therefore, the development of nonviral vectors is crucial to the progression and clinical use of gene therapy.14-15, 33 Non-viral gene
delivery vehicles such as cationic lipids and polymers have been extensively studied with reports
of high transfection efficiencies; however, a number of these studies have failed during clinical
trials.14-15 The challenges associated with utilizing non-viral vectors as gene delivery vehicles are
mainly due to the lack of knowledge or understanding of their molecular interactions with cells
and the overall gene delivery mechanism. Some known barriers to further developing polymeric
gene delivery vehicles include cellular uptake, endosomal escape, and the efficient delivery of
genetic material to the nucleus.14-15, 34 To overcome these challenges, pH-responsive polymers
such as poly(ethyleneimine) (PEI) have been developed and studied for their ability to capitalize
on the pH gradients of the endosomal pathway.35 Though PEI is known to have high efficiency of
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polyplex formation as well as high gene expression, this polymer induces immunogenic responses
both in vitro and in vivo because of it nonspecific interactions with various proteins and cells.14-15
Moreover, there is a lack of control over the resulting molecular weight and architecture of PEI
and other cationic polymers utilized for gene delivery vehicles.4,

36

These limitations of

biocompatibility and polymerization control have stimulated further research and development of
alternative polymeric gene delivery vehicles.
In order to improve the biocompatibility of cationic polymers for gene delivery, a
hydrophilic component such as poly(ethylene glycol) (PEG) can be incorporated into the polymer
design to afford stability in aqueous environments.3,

22-24, 31

A number of studies have discussed

the positive effects of PEGylated copolymers on gene delivery efficiency with results including
the decrease in immunogenicity and cellular toxicity and overall improvement in the polyplex
stability in vitro.22-24 Studies such as those by Deshpande et al. and Venkataraman et al. have
reported that varying the PEG architecture has an effect on the delivery efficiency of genetic
material and indicate that a block copolymer structure has better delivery efficiency than that of a
statistical copolymer.22-24
With the advent of controlled radical polymerization (CRP) techniques, reversible
addition-fragmentation chain transfer (RAFT) polymerization in particular, the synthesis of welldefined molecular weight polymers with low polydispersity is now possible.1-2 One significant
adaptation of RAFT polymerization is the advancement in the ability to produce water-soluble,
functional polymers that are inherently biocompatible, ideal for the development of gene delivery
vehicles.3-4, 10 Many studies have reported on the use of tertiary amine-containing monomers for
use as the cationic building blocks for gene delivery vehicles. Of these, DMAEMA has been the
most extensively studied since the first reports of CRP and RAFT polymerization due to its high
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transfection efficiency and endosomal destabilizing properties.25-27, 37 A number of studies have
elucidated the effects of PEGylated DMAEMA polymers with incorporated hydrophobic content
as effective gene delivery vehicles.28, 31 The role of tertiary amine functionality alone on the nucleic
acid delivery efficiency has yet to be discussed.
Here, we report on the biological efficacy of a series of diblock copolymer gene delivery
vehicles. Utilizing RAFT polymerization to ensure the controlled synthesis of well-defined block
copolymers with narrow PDIs, we designed and synthesized a family of tertiary amine-based
PEGylated copolymers incorporating oligo(ethylene glycol) methyl ether methacrylate (OEGMA)
to promote biocompatibility as well as colloidal stability and 2-(dimethylamino) ethyl
methacrylate

(DMAEMA),

2-(diethylamino)

ethyl

methacrylate

(DEAEMA),

or

2-

(diisopropylamino) ethyl methacrylate (DPAEMA) for nucleic acid complexation and endosomal
escape. To examine the effects of cationic functional groups and block length on gene delivery
efficiency, nine diblock copolymers were synthesized with varying degrees of polymerization in
order to analyze and elucidate the effects of different cationic moieties on polyplex formation and
in vitro delivery.

3.3

Experimental Procedures

3.3.1

Materials
All chemicals were purchased from Sigma-Aldrich at the highest available purity and used

as received unless otherwise noted. OEGMA (Mn = 475 g/mol), DMAEMA, DEAEMA,
DPAEMA were passed through a column of basic alumina to remove inhibitor prior to
polymerization.
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3.3.2

Polymer Synthesis
Utilizing RAFT polymerization, a solution of OEGMA (59.4 g, 125 mmol), 4-cyano-4-

[(dodecylsulfanylthiocarbonyl)sulfanyl] pentanoic acid (CDP) (1.01 g, 2.5 mmol), and 4,4’azobis(4-cyanovaleric acid) (V-501) (140 mg, 0.5 mmol) in 445 mL DMSO were added to a 1000
mL round bottom flask fitted with a rubber stopper. This solution was sparged with nitrogen for
30 minutes and placed in a 70°C preheated oil bath. The polymerization was allowed to proceed
for 2 hours prior to termination by exposure to air. The resulting polymer was purified by dialysis
against water for 3 days and then subsequently recovered by lyophilization.
The resulting OEGMA macroCTA was chain extended with DMAEMA (pKa 7.4),
DEAEMA (pKa 7.2), or DPAEMA (pKa 6.9) to form the desired block copolymers. For all block
copolymerizations, the [M]ₒ/[CTA]ₒ and [CTA]ₒ/[I]ₒ were 125:1 and 10:1 respectively. As an
example, a solution of DMAEMA (2.36 g, 15 mmol), pOEGMA macroCTA (2.2 g), and V-501
(3.4 mg, 0.012 mmol) in 12.5 mL of DMF was added to a 40 mL glass reaction vial fitted with a
septa cap. The solutions were sparged with nitrogen for 20 minutes prior to polymerization in a
70°C preheated Thermo Scientific MaxQ 2000 Shaker coupled with a J-KEM temperature
controller. The polymerization was allowed to proceed for 2.75 hours prior to termination by
exposure to air. The resulting diblock copolymer, p(OEGMA-b-DMAEMA), was purified by
dialysis against DI water for three days prior to lyophilization.

3.3.3

Polymer Characterization
Gel permeation chromatography (GPC) was used to determine the number-average

molecular weight (Mn) and polydispersity indices (PDIs) of the diblock copolymers. Utilizing a
Thermo Scientific Dionex pump (UltiMate 3000 Pump) and paired autosampler (UltiMate 3000
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Autosampler Column Compartment), an aqueous eluent of 1 wt% acetic acid/ 0.10 M Na2SO4 (aq)
at a flow rate of 0.25 mL/min was employed. Eprogen Inc. columns [CATSEC 1000 (7 μ, 50 x
4.6), CATSEC 100 (5 μ, 250 x 4.6), and two CATSEC 300 (5 μ, 250 x 4.6)] connected in series
were coupled with a Wyatt miniDAWN TREOS multi-angle light scattering detector (λ = 690 nm)
and a Wyatt Optilab t-REX differential refractive index (dRI) detector (λ = 690 nm). The dn/dc of
each homopolymer was measured utilizing the Wyatt Optilab t-REX; dn/dc values were
implemented into the Wyatt Technology ASTRA software calculations for absolute molecular
weight determination.

3.3.4

siRNA/Copolymer Complex Characterization
To verify the stable siRNA/polymer complexation, agarose gel electrophoresis was

utilized. A 46 nucleotide, single-stranded oligonucleotide comprised of the NHE III1 region of the
MYC promoter and labeled with the fluorescent dye Fluorescein (6-FAM) (0.25 μM, sequence:
5’-GCGCTTATGGGGAGGGTGGGGAGGGTGGGGAAGGTGGGGAGGAGAC-3’)

was

mixed with aqueous solutions of the diblock copolymers in Tris-Acetate EDTA (TAE) buffer at
pH values of 5,7, or 9. The theoretical charge ratio of the nitrogen in the polymers to phosphorous
in the nucleic acids (N/P) were calculated using the positively charged cationic blocks of
DMAEMA, DEAEMA, or DPAEMA and the negatively charged siRNA. N/P ratios ranging from
0 to 7 were utilized. The copolymer/siRNA mixtures were allowed to incubate for 30 minutes at
room temperature to allow for polyplex formation before 3μL of 50% glycerol and 1 μL of 6x
DNA loading dye were added. The polyplex samples were then loaded on 1% agarose gels with
1x GelGreen dye (Phenix Research, Candler, NC) made with TAE buffers at the same pH as
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incubation. Gels were subjected to 70V for 30 minutes before transillumination imaging on a
FotoDyne gel imager.
The size of the siRNA/copolymer complexes were characterized in varying pH solutions
by dynamic light scattering (DLS) utilizing a Malvern Zetasizer Nano ZS (Malvern Instruments
Ltd., Max 4 mW He-Ne laser, incident beam λ=633 nm) and accompanying Zetasizer Software.
Briefly, copolymers were incubated in water (pH 5, 7, and 9) with appropriate amounts of 6-FAM
(0.3 μM) at an N/P ratio of 3. Copolymers were allowed to condense the siRNA for 30 minutes at
room temperature before running measurements in triplet.

3.3.5

Cellular Uptake
To initially determine if this copolymer series was capable of cellular transfection, the

polymer/siRNA complexes were incubated with human embryonic kidney cells (HEK293)
maintained in a 37°C humid atmosphere containing 5% CO2. To measure the cellular uptake, cells
were seeded in 12-well plates at a concentration of 1 x 105 cells per well in 1 mL of media. The
cells were allowed to incubate overnight before addition of polymer/siRNA complexes. The next
day, polyplexes at an N/P ratio of 3 were prepared utilizing a 19-mer fluorescein-labeled scramble
siRNA (0.545 μM, Cell Signaling Technology) and the appropriate amounts of copolymer solution
and the reduced serum media Opti-MEM (GIBCO). The mixture was subsequently allowed to
incubate at room temperature for 30 minutes. Additionally, the siRNA was incubated at room
temperature with 1.2 μL of Fugene (Promega). The polyplexes and Fugene/siRNA complexes
were then added to the wells and allowed to incubate for 24 hours. The next day the media was
discarded and replaced to rid any free polymer or siRNA. The efficiency of the copolymer
mediated gene delivery was then qualitatively determined with use of a fluorescent enabled
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microscope by visualizing the fluorescence of the Fluorescein labeled siRNA that was successfully
delivered to the cells.

3.3.6

Cell Viability Assay
MCF-7 cells were seeded in 96-well plates at a concentration of 7.5 × 103 cells per well in

90 μL of media and were allowed to attach overnight. The following day, a 10x stock plate of
polyplex solutions diluted from 5 mM over a 5-6 log range in 0.5 log steps was made, and 10 μL
of this stock was added to the cell plate, in triplicate. The final high dose range was 0.08 – 500
μM. Cell-free wells with the same dose-range were plated, and served as measurements of
background absorption. 48 hr later, 20 μL of MTS + 5% PMS was added to each well and incubated
for ~2 hr before the absorption at 490 nm was measured on a BioTek Synergy 2 plate reader
(Winooski, VT). Background absorptions were subtracted, and data were normalized to control
cells to determine any changes in cell viability.

3.3.7

MYC Knockdown Studies
MCF-7 breast cancer cells were obtained fresh from ATCC (Manassa, VA) and were

maintained in exponential growth in Dulbecco’s minimal essential medium (DMEM) that was
supplemented with 10% fetal bovine serum and 1x penicillin/streptomycin solution in a 37°C
humid atmosphere containing 5% CO2. To measure cellular uptake, cells were seeded in two 12well plates at a concentration of 8 x 104 cells per well in 0.5 mL of media and allowed to attach
overnight. The following day, polyplexes were prepared as previously described with a 19-mer
MYC siRNA (Cell Signaling Technology, #6341) at an N/P ratio of 3. In addition, the siRNA was
complexed with 1.2 μL of Fugene HD (Promega) and incubated for 30 minutes at room
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temperature. The polyplexes were added to the wells and allowed to incubate for 48 hr. After the
48 hour period, the wells were rinsed with water, and the cells were collected by lysis buffer. After
subsequent β-mercaptoethanol (BME) addition, all samples were frozen for future analysis.
Once samples were thawed, the RNA was extracted with the use of a Roche GeneJET kit
(Roche, Basel, Switzerland) according to the kit directions. The yield and purity of the RNA was
determined with the use of a NanoDrop-1000 (NanoDrop); only samples with 260/230 values
greater than 1.5 were considered pure enough for continued use. 500 ng of RNA was reverse
transcribed into cDNA using the BioRad iScript kit according to the directions using a BioRad
Thermocycler. Quantitative polymerase chain reaction (qPCR) was run on the cDNA samples
using TaqMan primers (ABI). In particular, 5 μL of cDNA was evaluated by multiplexing FAMlabeled MYC primers (Life Technologies, Hs00153408_m1) with VIC-labeled GAPDH primers
(Life Technologies, catalog number 4326317E) using SsoAdvanced PCR Mix (BioRad) on a CFX
Connect qPCR machine (BioRad). Changes in RNA expression were determined by the Cq
method.

3.4

Results and Discussion

3.4.1

Polymer Synthesis
RAFT polymerization enabled the synthesis of well-defined AB diblock copolymers for

nucleic acid delivery. The pH-responsive diblock copolymers were synthesized according to
Scheme 3.1. The RAFT polymerization of OEGMA was initiated by V-501 and mediated by CDP
in DMSO. After purification, the OEGMA macroCTA was chain-extended with one of three
tertiary amine monomers, DMAEMA, DEAEMA, or DPAEMA, to yield a series of diblock
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copolymers with a permanently hydrophilic A block to impart water-solubility and provide steric
hindrance to aggregation and varying lengths of pH-responsive B blocks for nucleic acid
complexation. The degrees of polymerization of 25, 50, and 75 were targeted for the pH-responsive
B block in order to investigate the effect of the repeat unit structure and block length of the cationic
block on the delivery of nucleic acid payloads.
Scheme 3.1. RAFT polymerization of OEGMA and subsequent chain extension with tertiary
amine-containing monomers to form pH-responsive diblock copolymers for siRNA delivery.

3.4.2

Polymer Characterization
RAFT polymerization proved to be an effective methodology for controlling the degrees

of polymerization of the diblock copolymers while maintaining a low polydispersity index (< 1.1)
as shown in Table 3.1. To prove the successful chain extension of the OEGMA macroCTA, GPC
chromatograms of the macroCTA and P75 are depicted in Figure 3.1. P75 has a shorter elution
time as compared to the OEGMA macroCTA; therefore, P75 has a larger molecular weight
indicating the desired chain extension of the macroCTA and successful synthesis of amphiphilic
diblock copolymers. The slight tail observed with the P75 chromatogram can be attributed to a
small percentage of dead macroCTA polymer chains not capable of chain extension.
47

Table 3.1. Molecular weight data for the pH-responsive diblock copolymer series.

p(OEGMA38-b-DMAEMA27)

M25

Mn
(g/mol)
22,900

p(OEGMA38-b-DMAEMA51)
p(OEGMA38-b-DMAEMA76)
p(OEGMA38-b-DEAEMA29)
p(OEGMA38-b-DEAEMA50)
p(OEGMA38-b-DEAEMA73)
p(OEGMA38-b-DPAEMA29)
p(OEGMA38-b-DPAEMA53)
p(OEGMA38-b-DPAEMA74)

M50
M75
E25
E50
E75
P25
P50
P75

26,800
30,800
24,400
28,800
33,900
26,600
32,800
38,300

Polymer

PDI
1.02
1.02
1.01
1.03
1.05
1.04
1.04
1.04
1.02

1.2
OEGMA macroCTA

P75

Normalized RI Signal

1.0
0.8
0.6
0.4
0.2
0.0
21

23

25

27
29
Elution Time (min)

31

33

35

Figure 3.1. GPC chromatogram indicating the successful chain extension of the OEGMA
macroCTA with DPAEMA. The P75 copolymer has a shorter elution time from the GPC columns
indicating that it has a larger molecular weight than the macroCTA.

3.4.3

siRNA/Copolymer Characterization
The ability of the pH-responsive diblock copolymers to bind with nucleic acids was

assessed via electrophoretic gel shift assays. The three protonatable tertiary amine-contianing B-
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blocks have pKa values varying from 6.9 for DPAEMA to 7.4 for DMAEMA. We tested the
nucleic acid binding abilty of the diblock copolymers at pH values of 5, 7, and 9 to examine the
pH effect on the binding affinity of the diblock copolymers. Figure 3.2 shows a representative
series of gel shift assays for the diblock copolymers with a targeted B block degree of
polymerizaiton of 50.

Figure 3.2 Gel shift assays for the diblock copolymers M50, E50, and P50. pH values of 5, 7, and
9 with N/P ratios ranging from 0 (no polymer added) to 7 were utilized. The percent of the B block
moieties protonated is shown for each gel shift experiment.
At a pH of 5 where ~ 99% of the tertiary amine moieties are protonated, M50, E50, and
P50 bind DNA at the low N/P ratio of 1 indicted by the fluorescent signal remaning in the wells.
The somewhat low florescense signal for all samples at pH 5 can be explained by the reported
effect of low pH environments on the fluoresnce of molecules including Fluroroscein38. If the pH
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value of the buffer is increased to 7, the percentage of protonated tertiary amine moieties decreases,
but has only a minimal effect, if any, on the nucleic acid binding. As the pH of the buffer is further
increased to a value of 9, the tertiary amine groups become mostly deprotonated (>98%) and has
a dramatic effect on the ability of the diblock copolymers to complex with nucleic acids. For all
diblock copolymers tested at pH 9, minimal NA binding was observed for all tested N/P ratios 0
to 7.
To further characterize the siRNA/copolymer, DLS was employed to analyze the pHdependent nature of the copolymers by determining the polyplex size at varying pH. Utilizing a
theoretical charge ratio of 3:1, the polymers and nucleic acid material were allowed to incubate in
water at pH 5, 7, and 9 before DLS measurements. From this characterization, it was determined
that the polyplex diameter at pH 5, 7, and 9 for all copolymers investigated was less than 25 nm
making them ideal for cellular uptake. As an example, Figure 3.3 illustrates the DLS data for M50
complexed with siRNA in water at pH 5, 7, and 9. A shift to larger diameters with increasing pH
is expected and observed. When not complexed with genetic material, the pKa of DMAEMA is
7.4. At the lower pH, therefore, the vast majority of the tertiary amines would be protonated
causing the siRNA/polymer complexes to be more tightly bound. This strong binding affinity is
indicated by the smaller diameter in the pH 5 solution. The polyplex size then increases with
increasing pH since less of the tertiary amine side chains will be protonated. This decrease in
positively charged moieties causes the polyplex to have less molecular interactions with the nucleic
acids which in turn causes the polyplex to swell indicated by the larger particle size.

50

20
pH 5

pH 7

pH 9

Volume (%)

15

10

5

0
1

10
size (d.nm)

100

Figure 3.3 DLS measurements of M50 characterizing the pH-responsive nature of the tertiary
amine-based polymers. The data shows that for increasing pH, the polyplex diameter increases as
well indicating the pH dependent behavior of this diblock copolymer family.
3.4.4

siRNA/Copolymer Cellular Uptake
The ability of the copolymers to deliver genetic material to cells at an N/P ratio of 3 was

determined by the in vitro experiments utilizing the HEK293 cell line. This in vitro study was
utilized to gain preliminary results of the polymer-mediated gene delivery efficiency in order
determine if the copolymer series should be further pursued with more mature studies and
experimentation. The polymers were incubated with the siRNA for thirty minutes to allow for
polyplex formation before being added to the cell culture to incubate for 24 hours. After this period,
the fluorescent levels of fluorescein were qualitatively evaluated utilizing a fluorescent enabled
microscope. The images collected from this copolymer mediated cellular uptake study are shown
in Figure 3.4 along with the two controls of siRNA only and Fugene mediated delivery. Overall,
we noticed some degree of fluorescence with all nine cultures indicative of successful polymeric
nucleic acid delivery; however, E50, P50, and P75 visually appear to have delivered the highest
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concentration of the nucleic acid material, as indicated by the stronger fluorescence signal. Though
further investigations would be required, we know this copolymer series is capable of effectively
delivering genetic material to HEK293 cells.

Figure 3.4 In vitro study utilizing HEK293 cell line to determine the cellular update ability of the
siRNA/copolymer complexes with a fluorescing signal indicating effective gene delivery.

3.4.5

Copolymer Toxicity
In order to evaluate the effect of the tertiary amine functionalities and cationic block length

on cell viability, the copolymers were analyzed for their ability to induce an immunogenic
response. To investigate these cytotoxic effects, the copolymers were incubated with MCF-7 cells
for 48 hours after which time MTS viability assays were utilized for characterization. The resulting
cell viability after the subtraction of background absorption and data normalization to the control
is shown in Figure 3.5. High levels of cell viability (>90% after 48 hr) were observed for all
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copolymers tested with the exception of E50 and E75 which indicate high levels of toxicity (<50%
cell viability). Here, the addition of the hydrophilic block did not significantly affect the toxicity
levels of E50 and E75 as expected.

140

Normalized Cell Viability

120
100
80
60

*

*

40
20
0
Control

M25

M50

M75

E25

E50
E75
P25
P50
P75
*p<0.05 versus control by One-way ANOVA

Figure 3.5 Cytotoxicity study of the copolymer series. Most polymers were nontoxic with the
exception of E50 and E75 proving to be significantly toxic to the cell line.

3.4.6

Polyplex-Mediated Gene Knockdown
In order to investigate the ability of the copolymers to effectively deliver genetic material

to the nucleus, gene knockdown experiments in MCF-7 cells were employed utilizing the polyplex
N/P ratio of 3:1. The siRNA/polymer complexes were incubated with the MCF-7 cells for 48
hours. After this time, MYC expression was evaluated and normalized to GAPDH with the
resulting data illustrated in Figure 3.5. All polymers with the exception of P75 express a significant
decrease in the MYC expression as compared to that of FuGene; therefore, the block polymers
indicate potential for successful gene delivery vehicles. Interestingly, there is not an apparent
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trend for the different tertiary amine functional groups or degrees of polymerization; however,
there are differences among each respective series. Among all polymers, a significant difference
in the MYC knockdown is not observed so one block copolymer cannot be named superior over
the others studied.
As reported, E50 and E75 induce a toxic response in MCF-7 cells resulting in low cell
viability. Though they induce this cytotoxic activity, these two block copolymers are still capable
of gene knockdown. This experiment was designed to normalize the inputs as well as the results
in order to take cell death into consideration. Normalizations included the cDNA input, the MYC
to GAPDH expression, and the polymer treatments to the control. Figure 3.5, therefore, indicates
that E50 and E75 are plausible candidates for a viable gene delivery vehicle despite their toxic
effect.

1.2
1
0.8
0.6
0.4
0.2
0
Control siRNA FuGene M25
only

M50

M75

E25

E50

E75

P25

P50

P75

Figure 3.5 qPCR results indicating a significant decrease in the MYC expression for the
copolymers as compared to FuGene with the exception of P75.
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3.5

Conclusions
The advent of RAFT polymerization offers many advantages to the synthesis of

biologically compatible block copolymers in that well-defined molecular weight and architectures
are now possible. The use of this polymerization method has brought many advances to the
potential use of gene-based therapies in a clinical setting. Here, we have reported on the
development of a novel, diblock copolymer series capable of condensing genetic material and
escaping the endosome by means of a pH-responsive endosomolytic block. These copolymers
were synthesized with a biocompatible A-block composed of OEGMA and a cationic B-block of
DMAEMA, DEAEMA, or DPAEMA with the aim to separate out the effects of repeat unit
structure and block length of the cationic block on the efficiency of nucleic acid delivery. The
results determined from this study indicate a link between cationic block length and repeat unit
structure on the gene delivery efficacy. Pairing the low toxicity and effectiveness, this copolymer
family will enable further studies and development for promising gene delivery vehicles capable
for clinical use.

55

CHAPTER 4
FUTURE DIRECTIONS
From our studies, we have successfully developed an efficient nucleic acid delivery vehicle
that exhibits high cell viability and cell transfection. Moving forward, we hope to further
investigate these pH-responsive block copolymers by characterizing their affinity and delivery
efficiency of a G-quadruplex (G4) clamp as developed by the research team led by Tracy Brooks.
It has been reported that G-quadruplexes appear in the promoter region of the MYC oncogene, and
their stabilization leads to downregulation of MYC expression.39 The G4 clamp is composed of
complementary sequences to flank either side of the G-quadruplex of the promoter region held
together by a linker sequence. Once this G4 clamp is bound, the quadruplex is stabilized and gene
expression decreases. Should the copolymers presented in this study effectively deliver this Gquadruplex clamp, we can stabilize the quadruplex and cease MYC expression.
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VITA
ANNIE KATHERINE MCCLELLAN
EDUCATION
University of Mississippi (2013 - Present)
Oxford, MS
M.S. Engineering Science, Chemical Engineering Emphasis
NASA/Mississippi Space Grant Consortium Fellow
Anticipated Graduation Date: May 2016 Cumulative GPA: 3.33
Master’s Thesis: “RAFT Polymerization of pH-Responsive, Diblock Copolymers for Nucleic
Acid Delivery Vehicles”
University of Mississippi (2008-2013)
Oxford, MS
B.S. Chemistry
B.A. Biological Sciences, Mathematics Minor
Graduation date: May 2013 Magna Cum Laude Cumulative GPA: 3.79
Honor’s Thesis: “Spectroscopic Study of Charge Transfer Induced Blue Shifting of
Pyrimidine/Water Mixtures on Silver Substrate”

WORK EXPERIENCE
ExxonMobil Refining and Supply (August – December 2015)
Baytown, TX
Coordination and Product Quality Department, Profitability Co-op (Fall 2015)
 Enhanced SQL and VBA coding skills by incorporating queries and macros into a new
Excel tool that acquires and organizes plant simulation data
 Learned to bridge economic and technical considerations to make the most profitable
decisions for daily plant operation
 Advanced hazard recognition skills by developing two different safety procedures to be
used as safety assessment resources by fellow employees
 Matured leadership qualities as sub-project lead for United Way Day of Caring
ExxonMobil Chemical Company (January – August 2015)
Baytown, TX
Planning and Technology Section, Planning Co-op (June – August 2015)
 Gained experience developing project scope for potential capital expenditures
 Determined solution to a new feedstock option with potential to save the plant $7.5M/yr
 Advanced critical thinking and technical skills by solving challenges and determining
the most economic course of action for multiple project progressions
 Further developed technical presentation skills by presenting project findings to an
audience of piers, supervisors, and managers
Business and Technical Department, Technical Co-op (January – May 2015)
 Utilized design practices and technical knowledge to design restriction orifices that
increase furnace safety reliability and decrease maintenance costs of operation
 Developed skills in VBA and further refined coding ability by creating a monitoring
tool utilizing Excel VBA to pull, organize, and graph plant data
 Introduced to EPA and other environmental agency regulations; utilized these
regulations to create a console alarm to reflect permit updates for the site
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RESEARCH EXPERIENCE
Graduate Research Assistantship (2013-2016)
Oxford, MS
“RAFT polymerization for the synthesis of tertiary amine-based diblock
copolymer nucleic acid delivery vehicles” (to be submitted Spring 2016)
 Developed skills in RAFT polymerization of uniform biopolymers
 Gained experience in gel permeation chromatography (GPC), nuclear magnetic
resonance (NMR) spectroscopy, and dynamic light scattering (DLS)
 Became proficient with utilizing electrophoresis and in vitro methods to study the
binding affinity and gene delivery efficiencies of amphiphilic copolymers
 Responsible for accuracy and maintenance of the GPC
 Conference presentations:
 2014 AIChE Annual Meeting
 2013 National Graduate Research Polymer Conference
NASA Mississippi Space Grant Consortium Fellow (2014-2015)
Oxford, MS
“Polymer-functionalized graphene nanosheets utilizing RAFT polymerization”
 Assisted a local middle school robotics group on the development of their robot for
competition
 Utilized RAFT polymerization to develop graphene functionalized nanomaterials
University of Mississippi Undergraduate Research, University, MS (June 2010 – May 2013)
“Surface Enhanced Raman Spectroscopy (SERS) of Pyrimidine Mixtures”
 Introduced to research methods and how to overcome obstacles to see a project to
completion
 Learned how to effectively communicate in a technical language as well as how to
tailor a presentation for varying audiences
 Developed skills in vapor deposition techniques and accumulating Raman and SERS
spectra
 Utilized results of electronic structure computations to verify experimental results
 Conference poster presentations:
 245th National ACS Meeting 2013
 23rd National NSF EPSCoR Conference 2013
 2012 MS EPSCoR Meeting
 2011 MS EPSCoR Meeting
 242nd National ACS Meeting 2011
 SWRM/SERMACS 2010

PROFESSIONAL TRAINING
Light Scattering University Wyatt Technology, Santa Barbara, CA (July 2013)
 Week long professional training of light scattering analytical equipment
 Participated in light scattering seminars on the principles behind Rayleigh and Raman
scattering
 Received highest overall grade of the training class
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Diamond Anvil Cell High Pressure Raman Spectroscopy Symposium (August 2011)
easyLab Technologies, Ltd. University of Reading, Reading, UK
 Instruction of use and application of a diamond anvil cell for high pressure
spectroscopic research

ADDITIONAL INVOLVEMENT






AIChE Member: 2013 to Present
United Way Volunteer
2016 Bike & Build Rider
2014 Graduate Student Council
Sally McDonnell Barksdale Honors Scholar
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ACS Member: 2010 to Present
Habitat for Humanity Volunteer
ExxonMobil Cycling Team
Church ministry involvement
2013 President of Local Student ACS Chapter

